21 CFR 522.1484

§ 522.1484 Neomycin.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.1484, § 522.1484 Neomycin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87492
Permanent ID: ys:prov:87492@1
SHA-256: d86abce79dbfbeefa7a0e399c3dafbc3793bdf110f6d17edde01f0bb04c8085e

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 50 milligrams (mg) of neomycin sulfate (equivalent to 35 mg of neomycin base). (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amount. Administer 5 mg per pound of body weight daily by intramuscular or intravenous injection, divided into portions administered every 6 to 8 hours for 3 to 5 days. (2) Indications for use. For the treatment of acute and chronic bacterial infections due to organisms susceptible to neomycin. (3) Limitations. Not for parenteral use in food-producing animals because of prolonged residues in edible tissues. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.